Division of Pharmaceutics, College of Pharmacy, The University of Iowa, Iowa City, USA.
Biopharm Drug Dispos. 2011 Apr;32(3):131-9. doi: 10.1002/bdd.743. Epub 2011 Jan 10.
A feedback receptor regulation model was incorporated into a pharmacodynamic model to describe the stimulation of hemoglobin (Hb) production by endogenous erythropoietin (EPO). The model considers the dynamic changes that take place in the EPO receptor (EPOR) pool under phlebotomy-induced anemia. Using a (125)I-rhEPO tracer the EPO clearance changes are evaluated longitudinally prior to and following phlebotomy-induced anemia indirectly to evaluate changes in the EPOR pool size, which has been shown to be linearly related to the clearance. The proposed model simultaneously captures the general behavior of temporal changes in Hb relative to EPO plasma clearance in five lambs (r = 0.95), while accounting for the confounding variables of phlebotomy and changes in the blood volume in the growing animals. The results indicate that under anemia the EPOR pool size is up-regulated by a factor of nearly two over baseline and that the lowest and highest EPOR pool sizes differ by a factor of approximately four. The kinetic model developed and the data-driven mechanism proposed serves as a starting point for developing an optimal EPO dosing algorithm for the treatment of neonatal anemia.
将反馈受体调节模型纳入药效动力学模型,以描述内源性促红细胞生成素(EPO)对血红蛋白(Hb)生成的刺激作用。该模型考虑了在放血诱导性贫血下 EPO 受体(EPOR)池发生的动态变化。使用(125)I-rhEPO 示踪剂,在放血诱导性贫血之前和之后进行纵向评估 EPO 清除率的变化,间接评估 EPOR 池大小的变化,已经证明 EPOR 池大小与清除率呈线性相关。该模型同时捕捉了五只羔羊中 Hb 相对于 EPO 血浆清除率的时间变化的一般行为(r = 0.95),同时考虑了放血和生长中动物血液量变化的混杂变量。结果表明,在贫血情况下,EPOR 池大小相对于基线上调了近两倍,最低和最高 EPOR 池大小相差约四倍。所开发的动力学模型和提出的数据驱动机制为开发用于治疗新生儿贫血的最佳 EPO 给药算法提供了起点。